Literature DB >> 18535595

Bilateral improvement of persistent diffuse diabetic macular oedema after unilateral intravitreal bevacizumab (Avastin) injection.

R Scartozzi, J R Chao, A C Walsh, D Eliott.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18535595     DOI： 10.1038/eye.2008.162

Source DB:  PubMed          Journal:  Eye (Lond)        ISSN： 0950-222X            Impact factor:   3.775


× No keyword cloud information.
  3 in total

1.  Fellow eye effect of unilateral intravitreal bevacizumab injection in eyes with diabetic macular edema.

Authors:  J Hanhart; L Tiosano; E Averbukh; E Banin; I Hemo; I Chowers
Journal:  Eye (Lond)       Date:  2014-05-23       Impact factor: 3.775

Review 2.  Off-label use of bevacizumab for the treatment of age-related macular degeneration: what is the evidence?

Authors:  Focke Ziemssen; Salvatore Grisanti; Karl Ulrich Bartz-Schmidt; Martin S Spitzer
Journal:  Drugs Aging       Date:  2009       Impact factor: 3.923

3.  The effect of intravitreal bevacizumab and ranibizumab on macular edema of the contralateral eye: A comparative study of two anti-VEGFs.

Authors:  Berker Bakbak; Banu Turgut Ozturk; Saban Gonul; Sansal Gedik
Journal:  Oman J Ophthalmol       Date:  2016 Jan-Apr
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.